The Bruton's Tyrosine Kinase Inhibitor PCI-32765 Is Highly Active As Single-Agent Therapy in Previously-Treated Mantle Cell Lymphoma (MCL): Preliminary Results of a Phase II TrialLühua Wang, André Goy, Michael E. Williams et al.|Blood|2011Cited by 41
Lipid metabolism analysis in esophageal cancer and associated drug discoveryRuidi Jiao, Chao Zhao, Wei Jiang et al.|Journal of Pharmaceutical Analysis|2023Cited by 20
Immunotherapy enhances the risk of tumor oxidative stress and metastasis in lung cancer with radiation pneumonitisRuidi Jiao, Lühua Wang, Wei Jiang et al.|Frontiers in Immunology|2025Cited by 0